Parataxis Korea, Inc. (KOSDAQ:288330)
South Korea · Delayed Price · Currency is KRW 760.00
+1.00 (0.13%)
At close: Mar 12, 2026
Parataxis Korea Market Cap
Parataxis Korea has a market cap or net worth of 80.62 billion as of March 12, 2026. Its market cap has decreased by -64.46% in one year.
Market Cap
80.62B
Enterprise Value
62.77B
Revenue
10.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
760.00
Market Cap Chart
Since December 20, 2019, Parataxis Korea's market cap has decreased from 300.15B to 80.62B, a decrease of -73.14%. That is a compound annual growth rate of -19.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 80.62B | 2.71% |
| Dec 30, 2025 | 78.49B | -58.48% |
| Dec 30, 2024 | 189.04B | 158.57% |
| Dec 28, 2023 | 73.11B | -68.32% |
| Dec 29, 2022 | 230.80B | -17.53% |
| Dec 30, 2021 | 279.85B | 0.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cell Biotech | 98.48B |
| Progen | 97.02B |
| TegoScience | 95.76B |
| CTCBIO | 94.92B |
| KoBioLabs | 87.48B |
| Choong Ang Vaccine Laboratory | 86.93B |
| CHA Vaccine Research Institute | 79.52B |
| Naturalendo Tech | 77.99B |